AI assistant
Sending…
ACM Research, Inc. — Director's Dealing 2025
Nov 14, 2025
31514_dirs_2025-11-14_cdc2f1e7-a144-4c80-bb2a-df45266ee26a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ACM Research, Inc. (ACMR)
CIK: 0001680062
Period of Report: 2025-11-12
Reporting Person: Feng Lisa (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | Class A Common Stock | M | 15000 | $5.6 | Acquired | 65001 | Direct |
| 2025-11-12 | Class A Common Stock | S | 15000 | $32.76 | Disposed | 50001 | Direct |
| 2025-11-13 | Class A Common Stock | M | 15000 | $5.6 | Acquired | 65001 | Direct |
| 2025-11-13 | Class A Common Stock | S | 15000 | $33.77 | Disposed | 50001 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-11-12 | Stock Option | $5.6 | M | 15000 | Disposed | 2029-04-22 | Class A Common Stock (15000) | Direct |
| 2025-11-13 | Stock Option | $5.6 | M | 15000 | Disposed | 2029-04-22 | Class A Common Stock (15000) | Direct |
Footnotes
F1: On November 12, 2025, the reporting person exercised a previously issued stock option to purchase 15,000 shares of Class A Common Stock of the Issuer.
F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 13, 2025.
F3: On November 13, 2025, the reporting person exercised a previously issued stock option to purchase 15,000 shares of Class A Common Stock of the Issuer.
F4: The option is fully vested and exercisable.
More from ACM Research, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Regulatory Filings
2026
May 7
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 17
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 24